Sökning: "Oral glucose tolerance tests"
Visar resultat 6 - 10 av 19 avhandlingar innehållade orden Oral glucose tolerance tests.
6. Mechanism-Based Modeling of the Glucose-Insulin Regulation during Clinical Provocation Experiments
Sammanfattning : Type 2 diabetes is a complex chronic metabolic disorder characterized by hyperglycemia associated with a relative deficiency of insulin secretion and a reduced response of target tissues to insulin. Considerable efforts have been put into the development of models describing the glucose-insulin system. LÄS MER
7. Glucose regulation and coronary artery disease : studies on prevalence, recognition and prognostic implications
Sammanfattning : Coronary artery disease and diabetes mellitus type 2 represent chronic diseases of substantial and growing prevalence. Their coincidence is common, markedly enhancing mortality and morbidity. The risk for cardiovascular disease increases along a spectrum of blood glucose concentrations from levels regarded as normal. LÄS MER
8. Peripheral polyneuropathy in type 2 diabetes mellitus and impaired glucose tolerance. Correlations between morphology, neurophysiology, and clinical findings
Sammanfattning : Diabetic peripheral polyneuropathy (PN) is a common and serious complication of diabetes. The prevalence of PN is rising with the global burden of type 2 diabetes. The causal mechanisms of PN are not fully understood, but both vascular and metabolic factors play a role. LÄS MER
9. Diabetes mellitus, glucose abnormalities and acute coronary syndromes : studies on prevalence, risk and impact of treatment
Sammanfattning : Background: Persons with diabetes mellitus and impaired glucose tolerance are at increased risk for cardiovascular disease.The prevalence of known diabetes among patients with acute myocardial infarction, about 20%, is expected to increase in the coming decades. LÄS MER
10. Dysglycaemia and cardiovascular disease. Aspects on screening, management, and prognosis
Sammanfattning : Background: Dysglycaemia, in this thesis defined as impaired glucose tolerance (IGT) or type 2 diabetes (T2DM), is a major risk factor for cardiovascular disease (CVD). International guidelines recommend screening for dysglycaemia and target-driven lifestyle and pharmacological management in people with high cardiovascular (CV) risk or established CVD for both men and women. LÄS MER